Is there any advantage to combined trastuzumab and chemotherapy in perioperative setting her 2neu positive localized gastric adenocarcinoma?

Is there any advantage to combined trastuzumab and chemotherapy in perioperative setting her 2neu positive localized gastric adenocarcinoma?

<p>Abstract</p> <p>We report here a 44-year-old Moroccan man with resectable gastric adenocarcinoma with overexpression of human epidermal growth factor receptor 2 (HER2) by immunohistochemistry who was treated with trastuzumab in combination with chemotherapy in perioperative sett...

Full description

Bibliographic Details
Main Authors: Albouzidi Abderrahmane, Elkaoui Hakim, Fetohi Mohamed, Slimani Khaoula, Moussaid Yassine, Oukabli Mohamed, Kadiri Habiba, Debbagh Adil, Essaidi l Ismail, Sbitti Yassir, Mahi Mohamed, Ali Abdelmounaim, Ichou Mohamed, Errihani Hassan
Format: Article
Language:English
Published: BMC 2011-09-01
Series:World Journal of Surgical Oncology
Subjects:
trastuzumab
chemotherapy
perioperative
gastric adenocarcinoma
resection
Online Access:http://www.wjso.com/content/9/1/112

Internet

http://www.wjso.com/content/9/1/112

Similar Items